Clene

-$0.87 (-9.84%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Clene and other stocks, options, and ETFs commission-free!

About CLNN

Clene Inc. Common Stock, also called Clene, is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases.

CEO
Robert Dee Etherington
Employees
—
Headquarters
Salt Lake City, Utah
Founded
2013

CLNN Key Statistics

Market Cap
518.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
156.17K
High Today
$9.16
Low Today
$7.82
Open Price
$8.84
Volume
96.13K
52 Week High
$17.50
52 Week Low
$6.23

CLNN Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, Pre-Market

You May Also Like

SNAP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure